Needham & Company LLC initiated coverage on shares of Omada Health (NASDAQ:OMDA - Free Report) in a report released on Tuesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $23.00 price objective on the stock.
OMDA has been the subject of a number of other reports. Wall Street Zen raised Omada Health to a "hold" rating in a research report on Monday, June 16th. The Goldman Sachs Group started coverage on Omada Health in a research note on Tuesday. They set a "buy" rating and a $29.00 price target for the company. Finally, Canaccord Genuity Group started coverage on Omada Health in a research note on Tuesday. They issued a "buy" rating and a $27.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Omada Health has an average rating of "Moderate Buy" and a consensus price target of $23.57.
View Our Latest Research Report on Omada Health
Omada Health Stock Performance
Shares of OMDA stock traded up $0.53 during trading hours on Tuesday, hitting $18.63. 344,526 shares of the company were exchanged, compared to its average volume of 1,650,603. Omada Health has a 52-week low of $14.14 and a 52-week high of $28.40.
About Omada Health
(
Get Free Report)
Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.
Recommended Stories
Before you consider Omada Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.
While Omada Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
